Health & Wellness

Press Releases

Rafael Pharmaceuticals, in Collaboration with Atlantic Health System, Announces Initiation of a Phase I Study of CPI-613 in Combination with Gemcitabine and Nab-Paclitaxel for Patients with Locally Advanced or Metastatic Pancreatic Cancer

a07d2d57403ac43db2c4_Dr._Angela_Alistar_2017.jpg
a07d2d57403ac43db2c4_Dr._Angela_Alistar_2017.jpg

Rafael Pharmaceuticals, Inc., a clinical stage company and leader in the field of cancer metabolism-based therapeutics, announced today, the initiation of a Phase I clinical trial of CPI-613 in combination with chemotherapeutic agents, gemcitabine and nab-paclitaxel, for patients with locally advanced or metastatic pancreatic cancer. The study will be conducted in collaboration with Atlantic Health System. CPI-613 is a first-in-class drug with a unique mode of action and is Rafael’s lead altered energy metabolism directed (AEMD) drug candidate. The drug is designed to disrupt the altered energy-production pathways in cancer cells by targeting their mitochondrial metabolism.

The primary aim of the study is to establish the maximum tolerated dose of CPI-613 when given in combination with gemcitabine/nab-paclitaxel for patients with locally advanced or metastatic pancreatic cancer.

Secondary aims include:

Sign Up for E-News

(1) To describe the safety profile for the gemcitabine/nab-paclitaxel/CPI-613 combination.
(2) To determine the clinical activity of gemcitabine/nab-paclitaxel/CPI-613 in metastatic pancreatic cancer as measured by tumor response rate (RR) by RECIST criteria, progression-free survival (PFS), and overall survival (OS).

Encouraging results observed in earlier trials, including Phase I data from a trial led by Angela Alistar, MD that was recently published in The Lancet Oncology, demonstrated the preliminary efficacy of CPI-613 in combination with modified FOLFIRINOX (a multidrug treatment for advanced pancreatic cancer) in patients with metastatic pancreatic cancer. These results support further evaluation of CPI-613 in this indication.[1] The safety profile of CPI-613 in earlier trials, which shows the drug to be well tolerated, provides further support for evaluation of CPI-613 in combination with other drugs to maximize benefit.

In 2013, the MPACT study, a multinational, phase III clinical trial comparing gemcitabine/nab-paclitaxel to gemcitabine alone, demonstrated an improved median survival of 8.5 months as compared with 6.7 months for gemcitabine monotherapy (p=0.000015). While some clinical benefit was shown, these outcomes also highlight the need for new combination strategies to improve upon the outcomes seen with gemcitabine/nab-paclitaxel in the treatment of metastatic pancreatic cancer.

Dr. Alistar, medical director of GI Medical Oncology at the Carol G. Simon Cancer Center of Morristown Medical Center, Atlantic Health System, and the Principal Investigator for this trial, remarked, “Strategies to enhance our current standard of care options are sorely needed in pancreatic cancer. Due to the low toxicity profile of CPI -613 as a single agent, I anticipate good tolerance in combination with the gemcitabine/nab-paclitaxel regimen. I am excited to be able to offer this novel option to our patients with pancreatic cancer. Targeting metabolism in pancreatic cancer has a strong scientific rationale.”

Sanjeev Luther, Rafael Pharmaceuticals’ Chief Executive Officer, commented, “Our company’s motto of “One Patient at a Time” is especially relevant in this situation. Patients with a low tolerance for toxicity may not be eligible for the FOLFIRINOX combo. We believe that the gemcitabine/nab-paclitaxel regimen has the potential to be a potent treatment with less toxicity. It is especially meaningful for us to announce the initiation of this study on World Pancreatic Cancer Day.”

About Atlantic Health System

Atlantic Health System, headquartered in Morristown, N.J., is an integrated health care delivery system powered by a workforce of 16,000 team members dedicated to building healthier communities. The system is comprised of 350 sites of care, including six hospitals: Morristown Medical Center, Overlook Medical Center, Newton Medical Center, Chilton Medical Center, Hackettstown Medical Center and Goryeb Children’s Hospital. Atlantic Health System also supports communities through Atlantic Medical Group, Atlantic Rehabilitation, Atlantic Home Care and Hospice, and its subsidiary, Atlantic Ambulance Corporation. Atlantic Health System sponsors the Atlantic Accountable Care Organization, one of the larger ACOs in the nation, and Optimus Healthcare Partners. 

About Rafael Pharmaceuticals, Inc.

Rafael Pharmaceuticals, Inc. is a clinical-stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Rafael’s primary objective is to develop highly selective and effective agents with minimal toxic effects on normal cells and tissues. Rafael’s first-in-class clinical lead compound, CPI-613 is being evaluated in multiple Phase I, I/II, and II clinical studies. The U.S. Food and Drug Administration (FDA) has given Rafael approval to initiate pivotal clinical trials in pancreatic cancer and acute myeloid leukemia (AML), and has designated CPI-613 an orphan drug for the treatment of pancreatic cancer, AML, and myelodysplastic syndromes (MDS). The company's investors include IDT Corporation (NYSE: IDT). For more information, visit http://www.rafaelpharma.com/.

Safe Harbor Statement

This press release contains forward-looking statements. These statements relate to future events or the company’s future financial performance. In some cases, you can identify forward-looking statements by terminology such as "may", "will", "should", "expect", "plan", "anticipate", "believe", "estimate", "predict", "potential" or "continue", the negative of such terms, or other comparable terminology. These statements are only predictions. Actual events or results may differ materially from those in the forward-looking statements as a result of various important factors. Although we believe that the expectations reflected in the forward-looking statements are reasonable, such statements should not be regarded as a representation by the company, or any other person, that such forward-looking statements will be achieved. The business and operations of the company are subject to substantial risks which increase the uncertainty inherent in forward-looking statements. We undertake no duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements.

Reference

[1] Alistar A, Morris BB, Desnoyer R, et al. (2017). Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial. The Lancet Oncology. doi: 10.1016/S1470-2045(17)30314-5.

TAP Into Another Town's News:

You May Also Be Interested In

Sign Up for E-News

SOMA

A Tale of Two Very Different Town Administrator Searches

Both Maplewood and South Orange are looking for new town administrators at the same time, a rare occurrence.

And their approaches couldn’t be any more different.

Maplewood, whose long-time administrator Joseph Manning is retiring May 31, launched its search last month the old-fashioned way: hiring a recruiting firm and letting them do the heavy lifting (or more appropriately the ...

AtlantiCast

AtlantiCast: Episode 12

On this week’s episode of AtlantiCast, decade of excellence makes headlines, as Atlantic Health’s place on Fortune Magazine’s 100 Best Companies to Work For List leads off the newest episode of AtlantiCast. Also on this week’s show, check out the newest “hybrid” operating room at Morristown Medical Center and find out how Atlantic Health is helping local ...

AtlantiCast Medical Minute: Atlantic Orthopedic Institute’s Scoliosis and Spinal Deformity Center

On this episode of the AtlantiCast Medical Minute, we’ll take you inside the Atlantic Orthopedic Institute’s Scoliosis and Spinal Deformity Center, with the center’s director, Jason Lowenstein, MD.

Video Link: https://www.youtube.com/watch?v=1M7euCp86-c

Maplewood Police Blotter - Two Teens Arrested for Theft from Auto

February 20, 2018

February 12 - Theft; A resident from Burroughs Way reported that sometime over the past day, a snow blower was stolen from an open garage.

February 17- Theft from Auto; At approximately 5:15 p.m., two males were observed going through vehicles on Hillcrest Rd.  Officers responded to the area and were able to locate two males fitting the description. The males, 18 year ...

South Orange Police Blotter - Two Arrested for Robbery in South Orange

Adult Arrest - Robbery - Shawn Ray Newsome, a 20 year old Newark resident and a 17 year old juvenile were arrested on Saturday, Feb. 3, at approximately 10:45 p.m. for robbery. Two male victims reported that as they were walking on South Orange Ave near the Newark border, they were approached by three actors (described as black males wearing dark clothing and black masks) who ...

Blood Drives in SOMA: Maplewood on Feb. 22 and South Orange on Feb. 26

February 19, 2018

SOUTH ORANGE AND MAPLEWOOD, NJ - Due to winter storms and flu disrupting blood donations, the Red Cross is urging donors to donate and help maintain blood supply, according to a press release from the organization.

In January, severe winter weather forced about 600 blood drives to cancel, resulting in more than 17,500 uncollected blood and platelet donations. And, ...

Maplewood Seniors Enjoy a Visit from Alfalfa the Alpaca on Valentine's Day

MAPLEWOOD, NJ - If you were at the Maplewood Senior Center on Wednesday - which happened to be Valentine's Day - you would have seen the somewhat unusual sight of an alpaca. Alfalfa the Alpaca to be precise.

 

The visit from Alfalfa was the first in the "creature comfort" series from the Maplewood Recreation Department.

 

Maplewood Recreation Director Melissa ...

Upcoming Events

Fri, February 23, 12:00 PM

St. Andrew & Holy Communion Parish Hall, South Orange

Lenten Friday Fish Fry Dinners

Food & Drink

Carousel_image_982bc8344531b1a37c85_par_440

Fri, February 23, 7:00 PM

Par 440 Restaurant & Lounge, Short Hills

The Extra Rich In Class Dinner Show with E.R.I.C.

Arts & Entertainment Food & Drink

Carousel_image_af1b89eae735bf536426_par440_promo

Fri, February 23, 7:00 PM

Par 440 Restaurant & Lounge, Short Hills

The Extra Rich In Class Dinner Show with E.R.I.C.

Arts & Entertainment Food & Drink

Carousel_image_337d02082fcbf48f3beb_mms_presents_r_h_cinderella

Fri, February 23, 7:30 PM

Maplewood Middle School Auditorium, Maplewood

Maplewood Middle School Presents Rogers & ...

Arts & Entertainment Education

School Walkout Efforts Reach West Orange High School

February 22, 2018

WEST ORANGE, NJ — Hundreds of West Orange High School (WOHS) students participated in a peaceful walkout Wednesday afternoon in support of their fellow classmates in South Florida, where a gunman killed 17 people last week.

“They want to see change [in gun control],” said WOHS Principal Hayden Moore, who was present during the impromptu student-organized walkout.

Indictment Handed Down in Millburn Carjacking

TRENTON, NJ – An indictment was handed down in the November carjacking in Millburn where a 13-year old girl was allegedly grabbed by the neck and the suspect threatened to kill her. 

The 11-count state grand jury indictment charges Ahmed Anthony, 30, of Newark with conspiracy, carjacking, robbery and making terroristic threats among other charges. The conspiracy in the first-degree ...

Shouts of Racial Slurs Bring Police to Sparta Theatre

February 21, 2018

SPARTA, NJ – Sparta police were called to the New Vision Sparta Theater on Sunday night because of a woman shouting slurs in a screening of Black Panther.

Former New Jersey Assembly candidate Michael Grace was in the theater when two people started yelling racial slurs including “look at these ‘n-word’” and “can you believe these ...

Police: 15-Year-Old Westfield Boy Arrested in Strong Arm Robbery, Car Theft

WESTFIELD, NJ — A 15-year-old Westfield boy has been charged in the assault and robbery of another teen and, separately, car theft, according to Westfield police.

The boy, whose name was not released because he is a juvenile, was first arrested Jan. 9, along with a 16-year-old boy from Newark, when the two were caught by police Newark with a stolen Dodge Charger from ...

Parkland Moms Club Seeks Cards for Teachers and First Responders

February 22, 2018

In less then 24 hours, the Parkland Moms Club put a card making event together at the park next to the amphitheater which has turned into a massive memorial. Kids from infants to 5th graders helped create cards for teachers, first responders, and hospital workers. Paulina Splechta donated her amazing photography skills and sent us tons and tons of pictures. No matter your age, there is a way ...

Lightbridge Academy in Millburn Hiring Assistant and Lead Teachers

If you are passionate about educating and nurturing young minds, you may fit right in with our family! Lightbridge Academy is currently hiring Assistant and Lead Teachers to join our team and grow with us!

If you would like to learn more about the positions offered, you can reach us at 973-218-1800.

Two Towns Top $31k to End Gun Violence

Two Towns Top $31k to End Gun Violence
Facebook Fundraising Campaign Goes Viral in 50 Hours

South Orange Village President Sheena Collum and Maplewood Mayor Victor De Luca announced Wednesday that the joint Facebook fundraiser between the two communities to support Everytown for Gun Safety closed at 12 p.m. on Tuesday with $30,660 in donations from 645 individual donors.

“We ...